Peruvoside

	WikiDoc Resources for Peruvoside
Articles
Most recent articles on Peruvoside Most cited articles on Peruvoside Review articles on Peruvoside Articles on Peruvoside in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Peruvoside Images of Peruvoside Photos of Peruvoside Podcasts & MP3s on Peruvoside Videos on Peruvoside
Evidence Based Medicine
Cochrane Collaboration on Peruvoside Bandolier on Peruvoside TRIP on Peruvoside
Clinical Trials
Ongoing Trials on Peruvoside at Clinical Trials.gov Trial results on Peruvoside Clinical Trials on Peruvoside at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Peruvoside NICE Guidance on Peruvoside NHS PRODIGY Guidance FDA on Peruvoside CDC on Peruvoside
Books
Books on Peruvoside
News
Peruvoside in the news Be alerted to news on Peruvoside News trends on Peruvoside
Commentary
Blogs on Peruvoside
Definitions
Definitions of Peruvoside
Patient Resources / Community
Patient resources on Peruvoside Discussion groups on Peruvoside Patient Handouts on Peruvoside Directions to Hospitals Treating Peruvoside Risk calculators and risk factors for Peruvoside
Healthcare Provider Resources
Symptoms of Peruvoside Causes & Risk Factors for Peruvoside Diagnostic studies for Peruvoside Treatment of Peruvoside
Continuing Medical Education (CME)
CME Programs on Peruvoside
International
Peruvoside en Espanol Peruvoside en Francais
Business
Peruvoside in the Marketplace Patents on Peruvoside
Experimental / Informatics
List of terms related to Peruvoside

Peruvoside
Clinical data
ATC code	C01AX02 (WHO) ;
Identifiers
	IUPAC name (3S,5R,10R,13R,14S,17R)-3-[(2S,5R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy -13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17 -tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde;
CAS Number	1182-87-2;
PubChem CID	14449;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C30H44O9
Molar mass	548.665 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Peruvoside (or cannogenin thevetoside) is a cardiac glycoside^[1] for heart failure.^[2]

It is derived from Cascabela thevetia (Thevetia neriifolia).^[2]

↑ Arora, R. B.; Rangaswami, S. (1972). Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia neriifolia Juss: Chemical, Pharmacological, and Clinical Studies. New Delhi, India: Thomson. LCCN 78900408.
↑ ^2.0 ^2.1 Bhatia, M. L.; Manchanda, S. C.; Roy, S. B. (1970). "Haemodynamic Studies with Peruvoside in Human Congestive Heart Failure". British Medical Journal. 3 (5725): 740–743. doi:10.1136/bmj.3.5725.740. PMC 1701679. PMID 4919553.

Clinical data

ATC code	C01AX02 (WHO)
Identifiers
IUPAC name (3S,5R,10R,13R,14S,17R)-3-[(2S,5R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy -13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17 -tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
CAS Number	1182-87-2
PubChem CID	14449
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₀H₄₄O₉
Molar mass	548.665 g/mol